9 results
Pathophysiology of Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar Syndrome (HHS)
Absolute Insulin deficit:
 - Type I DM:
Pathophysiology ... of Diabetic Ketoacidosis ... #dka #hhs #pathophysiology ... #comparison #endocrinology ... #diabetes #diabetic
Diabetes Pathophysiology and Medication Targets

The ominous octet is one concept that summarizes the different pathophysiologic pathways
Diabetes Pathophysiology ... pathways that lead to hyperglycemia ... #Pathophysiology ... Medication #Targets #Drug ... #Endocrinology
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... or anti-hyperglycemic ... manage Type 2 diabetes ... pharmacotherapy #table #comparison ... #endocrinology
Pathogenesis and Pathophysiology of Diabetic Ketoacidosis (DKA)

DKA is a result of an absolute or relative insulin
of Diabetic Ketoacidosis ... depletion and hyperglycemia ... driven by insulin) shifts ... abnormalities, including hyperglycemia ... #Endocrinology
Diabetes Insipidus vs Syndrome of Inappropriate ADH (SIADH) - Comparison Table

Diabetes Insipidus - Inadequate ADH
SIADH -
Diabetes Insipidus ... ADH (SIADH) - Comparison ... Insipidus #SIADH #Comparison ... #Table #Pathophysiology ... Symptoms #Diagnosis #Endocrinology
Ketosis Disorders - Comparison Table
 • Starvation Ketosis
 • Alcoholic Ketoacidosis (AKA)
 • Diabetic Ketoacidosis (DKA)
Ketosis Disorders - Comparison ... Ketoacidosis (AKA) • Diabetic ... Euglycemic DKA • Hyperglycemic ... diagnosis #management #endocrinology ... #comparison #table
DKA vs HHS
 - Think of DKA and HHS on a spectrum of hyperglycemic emergencies
 -
a spectrum of hyperglycemic ... #DKA #HHS #comparison ... laboratory #diagnosis #endocrinology ... #comparison #diabetic ... #hyperosmolar #hyperglycemic
Understanding the pathophysiology of hyperglycemia

#DKA #Diabetic #Ketoacidosis #Endocrinology #Pathophysiology
Understanding the pathophysiology ... of hyperglycemia ... #DKA #Diabetic ... #Ketoacidosis #Endocrinology ... #Pathophysiology
Euglycemic Diabetic Ketoacidosis (EuDKA)
SGLT2 Inhibitors
Increasing Indications
Significant Adverse Drug Effects
Definition of EuDKA
 • Metabolic acidosis with pH
Euglycemic Diabetic ... Significant Adverse Drug ... level < 200 mg/dL Pathophysiology ... #Euglycemic #Diabetic ... diagnosis #management #endocrinology